Overexpression of phosphorylated-STAT3 and phosphorylated-ERK protein in dermatofibrosarcoma protuberans

European Journal of Dermatology

Volumn 16, Issue 3, 2006, Pages 262-265

  Lin, Nengxing ^a,b   Urabe, Kazunori ^a   Moroi, Yoichi ^a   Uchi, Hiroshi ^a   Nakahara, Takeshi ^a   Dainichi, Teruki ^a   Kokuba, Hisashi ^a   Tu, Yating ^b   Furue, Masutaka ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Dermatofibroma; DFSP; p ERK; p STAT3

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; STAT3 PROTEIN;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOFIBROSARCOMA PROTUBERANS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN EXPRESSION; SCHOOL CHILD; SKIN BIOPSY;

ADULT; AGED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PHOSPHORYLATION; STAT3 TRANSCRIPTION FACTOR;

EID: 33646685680     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Masuda M, Suzui M, Yasumatu R, Nakashima T, Kuratomi Y, Azuma K, Tomita K, Komiyama S, Weinstein IB. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Cancer Res 2002; 62(12): 3351-5.
2. YiJiang S, Anushree S, Hong W, Lichtenstein A, Gera J. Cyclin D1 and c-myc Internal Ribosome Entry Site (IRES)-dependent Translation Is Regulated by AKT Activity and Enhanced by Rapamycin through a p38 MAPK- and ERK-dependent Pathway. J Biol Chem 2005; 280(12): 10964-73.
3. Gloster Jr. HM. Dermatofibrosarcoma protuberans. Int J Dermatol 1996; 35: 335-74.
4. Fromowitz FB, Viola MV, Chao S, Oravez S, Mishriki Y, Finkel G, Grimson R, Lundy J. Ras p21 expression in the progression of breast cancer. Hum Pathol 1987; 8(12): 1268-75.
5. Horvath CM. STAT proteins and transcriptional responses to extracellular signals. Trends Biochem Sci 2000; 2: 496-502.
6. Ma XT, Wang X, Ye YJ, Du RY, Cui ZR. Relationship of Stat3 and its target gene products with malignancy in human colorectal carcinoma. Ai Zheng 2003; 22(11): 1135-9.
7. Garcia R, Bowman TL, Niu G, Yu H, Minton S, Muro-Cacho CA, Cox CE, Falcone R, Fairclough R, Parsons S, Laudano A, Gazit A, Levitzki A, Kraker A, Jove R. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 2001; 20: 2499-513.
8. Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernandez-Luna JL, Nunez G, Dalton WS, Jove R. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 1999; 10: 105-15.
9. Grandis JR, Drenning SD, Chakraborty A, Zhou MY, Zeng Q, Pitt AS, Tweardy DJ. Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro. J Clin Investig 1998; 102: 1385-92.
10. Song JI, Grandis JR. STAT signaling in head and neck cancer. Oncogene 2000; 19: 2489-95.
11. Fernandes A, Hamburger AW, Gerwin BI. ErbB-2 kinase is required for constitutive Stat3 activation in malignant human lung epithelial cells. Int J Cancer 1999; 83: 564-70.
12. Ni Z, Lou W, Leman ES, Gao AC. Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells. Cancer Res 2000; 60: 1225-8.
13. Burke WM, Jin X, Lin HJ, Huang M, Liu R, Reynolds RK, Lin J, et al. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells. Oncogene 2001; 20: 7925-34.
14. Xu Q, Briggs J, Park S, Niu G, Kortylewski M, Zhang S, Gritsko T, Turkson J, Kay H, Semenza GL, Cheng JQ, Jove R, Yu H. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene 2005: 1-10.
15. Xie TX, Wei D, Liu M, Gao AC, Ali-Osman F, Sawaya R, Huang S. Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene 2004; 23(20): 3550-60.
16. Satoshi L, Cynthia DB, Gary EG, Chada S, Ramesh R. Inhibition of Src kinase activity by ad-mda7 suppresses vascular enlothelial growth factor expression in prostate carcinoma cells. Mol Ther 2005; 12(4): 707-15.
17. Inous S, Branch CD, Gallick GE, Chada S, Ramesh R. Inhibition of Src kinase activity by ad-mda7 suppresses vascular endothelial growth factor expression in prostate carcinoma cells. Mol Ther 2005; 12(4): 707-15.
18. Debra L, Silver, Honami N, Cheng W, Montell DJ. Activated Signal Transducer and Activator of Transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility. Cancer Res 2004; 64: 3550-8.
19. Horiguchi A, Oya M, Shimada T, Uchida A, Marumo K, Murai M. Activation of signal transduction and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome. J Urol 2002; 168: 762-5.
20. Cai SQ, Zheng M, Chen LR. Overexpression of Phosphorylated-STAT3 and Phosphorylated-Akt correlated with the Invasion and Metastasis of cutaneous squamous cell carcinoma. J Dermatol 2005; 32: 354-60.
21. Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene 2003; 22: 319-29.
22. Chang F, Steelman LS, Lee JT, Shelton JG, Navolanic PM, Blalock WL, Franklin RA, McCubrey JA. Signal transduction mediated by the RasRaf MEKERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia 2003; 17: 1263-93.
23. Denhardt DT. Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling. Biochem J 1996; 318: 729-47.
24. Lee Jr. JT, McCubrey JA. The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia. Leukemia (Baltimore) 2002; 16: 486-507.
25. Kortylewski M, Heinrich PC, Kauffmann ME, Bohm M, MacKiewicz A, Behrmann I. Mitogen-activated protein kinases control p27/Kip1 expression and growth of human melanoma cells. Biochem J 2001; 357: 297-303.
26. Zhuang L, Lee CS, Scolyer RA, McCarthy SW, Palmer AA, Zhang XD, McCarthy SW, Palmer AA, Zhang XD, Thompson JF, Bron LP, Hersey P. Activation of the extracellular signal regulated kinase (ERK) pathway in human melanoma. J Clin Pathol 2005; 58(11): 1163-9.
27. Cohen Y, Xing M, Mambo E, Guo Z, Wu G, Trink B, Guo Z, Wu G, Trink B, Beller U, Westra WH, Ladenson PW, Sidransky D. BRAF mutation in papillary thyroid carcinoma. BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 2003; 95: 625-62.
28. Singer G, Oldt 3rd R, Cohen Y, Wang BG, Sidransky D, Kurman RJ, Shih I. Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst 2003; 95: 484-6.
29. Smalley KS. A pivotal role for ERK in the oncogenic behaviour of malignant melanoma? Int J Cancer 2003; 104: 527-32.
30. Park JI, Strock CJ, Ball DW, Nelkin BD. The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway. Mol Cell Biol 2003; 23: 543-54.
31. Sippel RS, Chen H. Activation of the ras/raf-1 signal transduction pathway in carcinoid tumor cells results in morphologic transdifferentiation. Surgery 2002; 6: 1035-9.
32. Naoki K, Chen TH, Richards WG, Sugarbaker DJ, Meyerson M. Missense mutations of the BRAF gene in human lung adenocarcinoma. Cancer Res 2002; 23: 7001-3.
33. Shimizu A, O'Brien KP, Sjöblom T, et al. The dermatofibrosarcoma protuberans-associated collagen type II/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB. Cancer Res 1999; 59: 3719-23.
34. Ross R, Raines EW, Bowen-Pope DF. The biology of platelet-derived growth factor. Cell 1986; 46(2): 155-69.
35. Hironobu I, Kunihiko T. Mitogenic activity of dermatofibrosarcoma protuberans is mediated via an extracellular signal related kinase dependent pathway. J Invest Dermatol 2002; 119: 954-60.